Piper Sandler’s $298 target on ABBV

ABBV AbbVie

$215 → $298 (+38%) by May 2027

Overweight · raises · said May 27, 2026 · 12-month default horizon

Open: judged on the close on May 27, 2027

The article this target came from

Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress

Yahoo Finance · May 27, 2026

Piper Sandler increased its price target for AbbVie Inc. (NYSE:ABBV) to $298 from $294 on May 14

Piper Sandler’s track record → AbbVie →

A fact about what Piper Sandler published, as reported by Yahoo Finance, not a recommendation from Dalsna Finance; Piper Sandler is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.